2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...
Meet the Veristat team at ASCO, May 31st to June 4th in Chicago
Oncology development expertise that turns complex data into confident regulatory direction
If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or are looking to recruit patients quickly to get your early phase trials running, or just need medical writing, biostatistical,or pharmacovigilance support for your programs – Veristat can help.
For 30 years, Veristat has helped pharmaceutical and biotech companies accelerate their clinical trials and commercialize their therapies by delivering Science-First solutions across the development lifecycle.
Oncology/Hematology Experience in the Past 5 Years
- +400 Clinical Trials & Consulting Projects
- +30 Marketing Applications (NDAs, BLAs, MAAs) Prepared
- 90% of global operations team members have oncology/hematology experience
We provide impactful solutions on a full-service or functional service basis, integrating strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel therapies.
Our expertise encompasses traditional cancer treatments, devices/diagnostics, and specialized therapies, including vaccines, gene and cell therapies, and immunotherapies.
Don't miss this opportunity to connect with us at the Conference and learn more about how Veristat is advancing the development of new oncology therapies.
The Science-First CRO.™
Schedule A Meeting
Veristat team members, AJ Mills, Vice President, Global Commercial, and Gabriela Rosu, Senior Director, Global Medical Affairs, will be at the venue, ready to listen to your needs and share Veristat’s expertise. Discover what makes Veristat a distinguished name in the clinical research industry.
Arrange a meeting by completing the form on the right side of this page.
Conference Details
Website: ASCO 2024
Schedule A Meeting
Meet with us at ASCO 2024 by filling out the form below.
5 min read
ASCO 2026: ADCs Are Redefining What Targeted Therapy Can Do
Jul 2, 2026 Veristat Blog
Antibody-drug conjugates — or ADCs — are not new. The concept of a "magic bullet" that delivers a cytotoxic payload...